MHRA has published a summer blog from Rob Reid, Deputy Director of Innovative Devices, providing an update on regulatory reform and plans to support innovation. It highlights how work is underway to deliver on the commitments outlined in the 10 Year Health Plan and Life Sciences Sector Plan to allow faster patient access to new technology and to boost growth in the UK sector by reducing duplicative regulatory costs. Alongside the publication in July of the Government response to MHRA’s consultation on Medical Devices Regulations, MHRA announced it will consult later in 2025 on the indefinite recognition of CE marked products. MHRA is also working to finalise the draft text of new legislation for Pre-Market measures, and is continuing to develop tools to support access to innovation.
MHRA publishes MedRegs blog
